FOCUS trial: results, potentialities and limits

Saba, Luca
First
;Balestrieri, Antonella;Serra, Alessandra;Politi, Carola;Murgia, Alessandro;Mannelli, Lorenzo
2019-01-01

Abstract

In January 2019 Lancet has published the paper “Effects of fluoxetine on functional outcomes after acute stroke (FOCUS): a pragmatic, double-blind, randomised, controlled trial” (1). The main purpose of this prospective trial was to asses if fluoxetine [a selective serotonin reuptake inhibitor (SSRI) drug] could improve recovery after stroke.
2019
postischemic brain; reuptake inhibitor; stroke; fluoxetine
Files in This Item:
File Size Format  
atm-07-S3-S152(1).pdf

Solo gestori archivio

Size 166.12 kB
Format Adobe PDF
& nbsp; View / Open   Request a copy
166.12 kB Adobe PDF & nbsp; View / Open   Request a copy

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Questionnaire and social

Share on:
Impostazioni cookie